CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.62%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$16.5B
AUM Growth
+$861M
(+5.5%)
Cap. Flow
-$376M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
30.08%
Holding
747
New
44
Increased
335
Reduced
212
Closed
49
Top Buys
| 1 |
Eli Lilly
LLY
|
$68M |
| 2 |
Qualcomm
QCOM
|
$56.3M |
| 3 |
Nu Holdings
NU
|
$53.7M |
| 4 |
Amazon
AMZN
|
$49M |
| 5 |
Banco Macro
BMA
|
$43.2M |
Top Sells
| 1 |
Vipshop
VIPS
|
$599M |
| 2 |
Apple
AAPL
|
$46.1M |
| 3 |
Adobe
ADBE
|
$41.4M |
| 4 |
Starbucks
SBUX
|
$30M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Technology | 33% |
| 2 | Healthcare | 27.47% |
| 3 | Financials | 9.69% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
argenx
ARGX
$45.9B
| $22.1M | 0.13% |
51,418
+13,265
| +35% | +$5.7M |
|
152
IDEAYA Biosciences
IDYA
$2.38B
| $22.1M | 0.13% |
629,019
-1,000
| -0.2% | -$35.1K |
|
153
Zebra Technologies
ZBRA
$16B
| $22M | 0.13% |
71,378
-353
| -0.5% | -$109K |
|
154
Pfizer
PFE
$141B
| $21.7M | 0.13% |
775,597
-532,565
| -41% | -$14.9M |
|
155
Lamb Weston
LW
$8.08B
| $21.7M | 0.13% |
257,953
-4,802
| -2% | -$404K |
|
156
Natera
NTRA
$23.1B
| $21.7M | 0.13% |
200,007
-28,001
| -12% | -$3.03M |
|
157
Revolution Medicines
RVMD
$7.57B
| $21.5M | 0.13% |
554,334
-29,616
| -5% | -$1.15M |
|
158
Illumina
ILMN
$15.7B
| $21.4M | 0.13% |
205,043
+10,998
| +6% | +$1.15M |
|
159
Molina Healthcare
MOH
$9.47B
| $21.2M | 0.13% |
71,285
+67,004
| +1,565% | +$19.9M |
|
160
Clean Harbors
CLH
$12.7B
| $21.1M | 0.13% |
93,259
-32,924
| -26% | -$7.45M |
|
161
Bentley Systems
BSY
$16.3B
| $21M | 0.13% |
425,009
+84,292
| +25% | +$4.16M |
|
162
Apellis Pharmaceuticals
APLS
$3.55B
| $20.8M | 0.13% |
543,035
-41,890
| -7% | -$1.61M |
|
163
United Therapeutics
UTHR
$18.1B
| $20.5M | 0.12% |
64,513
+61,573
| +2,094% | +$19.6M |
|
164
Bruker
BRKR
$4.68B
| $20.5M | 0.12% |
321,205
+220,278
| +218% | +$14.1M |
|
165
Sarepta Therapeutics
SRPT
$1.96B
| $20.4M | 0.12% |
129,000
-22,000
| -15% | -$3.48M |
|
166
Xenon Pharmaceuticals
XENE
$3.02B
| $20.3M | 0.12% |
521,836
-39,048
| -7% | -$1.52M |
|
167
Keros Therapeutics
KROS
$633M
| $20.2M | 0.12% |
441,855
-210,144
| -32% | -$9.6M |
|
168
Welltower
WELL
$112B
| $20M | 0.12% |
191,716
+2,855
| +2% | +$298K |
|
169
Syndax Pharmaceuticals
SNDX
$1.47B
| $19.9M | 0.12% |
970,106
-74,926
| -7% | -$1.54M |
|
170
Nuvalent
NUVL
$5.83B
| $19.9M | 0.12% |
262,008
-22,001
| -8% | -$1.67M |
|
|
SWTX
171
DELISTED
SpringWorks Therapeutics
SWTX
| $19.7M | 0.12% |
522,104
+321,476
| +160% | +$12.1M |
|
172
Marriott International Class A Common Stock
MAR
$71.9B
| $19.6M | 0.12% |
80,949
+7,491
| +10% | +$1.81M |
|
173
GE Aerospace
GE
$296B
| $19.4M | 0.12% |
122,331
-13,165
| -10% | -$2.09M |
|
174
Walmart
WMT
$801B
| $19.3M | 0.12% |
284,575
-8,721
| -3% | -$590K |
|
175
Apollo Global Management
APO
$75.3B
| $19.2M | 0.12% |
163,002
+11,866
| +8% | +$1.4M |
|